🇺🇸 FDA
Pipeline program

Sulopenem

IT001-106

Phase 1 small_molecule terminated

Quick answer

Sulopenem for Urinary Tract Infections is a Phase 1 program (small_molecule) at Iterum Therapeutics plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Iterum Therapeutics plc
Indication
Urinary Tract Infections
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials